189 related articles for article (PubMed ID: 30683173)
21. Role of Mannheimia haemolytica leukotoxin in the pathogenesis of bovine pneumonic pasteurellosis.
Jeyaseelan S; Sreevatsan S; Maheswaran SK
Anim Health Res Rev; 2002 Dec; 3(2):69-82. PubMed ID: 12665107
[TBL] [Abstract][Full Text] [Related]
22. Mucosal and parenteral vaccination against pneumonic pasteurellosis in cattle with a modified-live in-frame lktA deletion mutant of Mannheimia haemolytica.
Briggs RE; Tabatabai LB; Tatum FM
Microb Pathog; 2012 May; 52(5):302-9. PubMed ID: 22401911
[TBL] [Abstract][Full Text] [Related]
23. Recombinant Mannheimia haemolytica serotype 1 outer membrane protein PlpE enhances commercial M. haemolytica vaccine-induced resistance against serotype 6 challenge.
Confer AW; Ayalew S; Panciera RJ; Montelongo M; Wray JH
Vaccine; 2006 Mar; 24(13):2248-55. PubMed ID: 16430995
[TBL] [Abstract][Full Text] [Related]
24. Ovis aries CR4 is involved in Mannheimia haemolytica leukotoxin-induced cytotoxicity.
Lawrence PK; Dassanayake RP
Vet Immunol Immunopathol; 2010 Jun; 135(3-4):266-74. PubMed ID: 20060597
[TBL] [Abstract][Full Text] [Related]
25. Serologic responses of young colostrum fed dairy calves to antigens of Pasteurella haemolytica A1.
Hodgins DC; Shewen PE
Vaccine; 1998 Dec; 16(20):2018-25. PubMed ID: 9796059
[TBL] [Abstract][Full Text] [Related]
26. Maternally and naturally acquired antibodies to Mannheimia haemolytica and Pasteurella multocida in beef calves.
Prado ME; Prado TM; Payton M; Confer AW
Vet Immunol Immunopathol; 2006 Jun; 111(3-4):301-7. PubMed ID: 16386312
[TBL] [Abstract][Full Text] [Related]
27. Identification of immunogenic, surface-exposed outer membrane proteins of Pasteurella haemolytica serotype 1.
Pandher K; Murphy GL; Confer AW
Vet Microbiol; 1999 Mar; 65(3):215-26. PubMed ID: 10189196
[TBL] [Abstract][Full Text] [Related]
28. Complexities of the pathogenesis of Mannheimia haemolytica and Haemophilus somnus infections: challenges and potential opportunities for prevention?
Czuprynski CJ; Leite F; Sylte M; Kuckleburg C; Schultz R; Inzana T; Behling-Kelly E; Corbeil L
Anim Health Res Rev; 2004 Dec; 5(2):277-82. PubMed ID: 15984339
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of recombinant leukotoxin in protection against pneumonic challenge with live Pasteurella haemolytica A1.
Conlon JA; Shewen PE; Lo RY
Infect Immun; 1991 Feb; 59(2):587-91. PubMed ID: 1987075
[TBL] [Abstract][Full Text] [Related]
30. Bordetella bronchiseptica fimbrial protein-enhanced immunogenicity of a Mannheimia haemolytica leukotoxin fragment.
Rajeev S; Kania SA; Nair RV; McPherson JT; Moore RN; Bemis DA
Vaccine; 2001 Sep; 19(32):4842-50. PubMed ID: 11535337
[TBL] [Abstract][Full Text] [Related]
31. Expression of a modified Mannheimia haemolytica GS60 outer membrane lipoprotein in transgenic alfalfa for the development of an edible vaccine against bovine pneumonic pasteurellosis.
Lee RW; Cornelisse M; Ziauddin A; Slack PJ; Hodgins DC; Strommer JN; Shewen PE; Lo RY
J Biotechnol; 2008 Jun; 135(2):224-31. PubMed ID: 18440084
[TBL] [Abstract][Full Text] [Related]
32. Mannheimia haemolytica and its leukotoxin cause neutrophil extracellular trap formation by bovine neutrophils.
Aulik NA; Hellenbrand KM; Klos H; Czuprynski CJ
Infect Immun; 2010 Nov; 78(11):4454-66. PubMed ID: 20823211
[TBL] [Abstract][Full Text] [Related]
33. Sequence diversity of the immunogenic outer membrane lipoprotein PlpE from Mannheimia haemolytica serotypes 1, 2, and 6.
Ayalew S; Blackwood ER; Confer AW
Vet Microbiol; 2006 May; 114(3-4):260-8. PubMed ID: 16386856
[TBL] [Abstract][Full Text] [Related]
34. Immunogenicity of Pasteurella multocida and Mannheimia haemolytica outer membrane vesicles.
Roier S; Fenninger JC; Leitner DR; Rechberger GN; Reidl J; Schild S
Int J Med Microbiol; 2013 Jul; 303(5):247-56. PubMed ID: 23731905
[TBL] [Abstract][Full Text] [Related]
35. BHV-1 infection and inflammatory cytokines amplify the interaction of Mannheimia haemolytica leukotoxin with bovine peripheral blood mononuclear cells in vitro.
Leite F; Kuckleburg C; Atapattu D; Schultz R; Czuprynski CJ
Vet Immunol Immunopathol; 2004 Jun; 99(3-4):193-202. PubMed ID: 15135985
[TBL] [Abstract][Full Text] [Related]
36. Protective capacity of the Pasteurella haemolytica transferrin-binding proteins TbpA and TbpB in cattle.
Potter AA; Schryvers AB; Ogunnariwo JA; Hutchins WA; Lo RY; Watts T
Microb Pathog; 1999 Oct; 27(4):197-206. PubMed ID: 10502460
[TBL] [Abstract][Full Text] [Related]
37. Serum antibody responses of cattle vaccinated with partially purified native Pasteurella haemolytica leukotoxin.
Confer AW; Clinkenbeard KD; Gatewood DM; Driskel BA; Montelongo M
Vaccine; 1997; 15(12-13):1423-9. PubMed ID: 9302755
[TBL] [Abstract][Full Text] [Related]
38. Protection of ruminants by Pasteurella haemolytica A1 capsular polysaccharide vaccines containing muramyl dipeptide analogs.
Brogden KA; DeBey B; Audibert F; Lehmkuhl H; Chedid L
Vaccine; 1995 Dec; 13(17):1677-84. PubMed ID: 8719519
[TBL] [Abstract][Full Text] [Related]
39. LKTA and PlpE small fragments fusion protein protect against Mannheimia haemolytica challenge.
Guzmán-Brambila C; Quintero-Fabián S; González-Castillo C; de Obeso-Fernández del Valle Á; Flores-Samaniego B; de la Mora G; Rojas-Mayorquín AE; Ortuño-Sahagún D
Res Vet Sci; 2012 Dec; 93(3):1293-300. PubMed ID: 22840333
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of a multivalent Pasteurella haemolytica vaccine in bighorn sheep: safety and serologic responses.
Miller MW; Conlon JA; McNeil HJ; Bulgin JM; Ward AC
J Wildl Dis; 1997 Oct; 33(4):738-48. PubMed ID: 9391957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
